Part I: The Truth As We Have Been Told
CHD – Coronary Heart Disease (heart attack and stroke) is the number one killer of Americans. As such, we have been inundated with information about how to improve our chances of becoming more than just another statistic. Lifestyle changes are still the most recommended means to lower your risk for developing heart disease. But for those of us unwilling, or unable, to change there is a new “miracle” class of prescription drugs called Statins.
The medical profession believes that Statin drugs are the miracle cure for preventing heart disease. This information comes to them through the clever marketing and promotion of these medicines by their producers, the pharmaceutical industry. But have we been told the truth, or are we being sold a product that is not only ineffective, but also harmful to our health. You may recall a time when the Tobacco industry touted the safety of smoking and advertisements even went as far as to depict physician smoking. Now 50 years later we know the truth about the dangers of smoking. Fifty years from now, will we look back at the pharmaceutical industry as the latest group to jeopardize our health for their own financial profits?
I intend to shed light on the true facts of these dangerous medications. It is my opinion that any informed individual would never voluntarily pollute their body with these toxic drugs. Furthermore, educated physicians should ensure these medications are used appropriately and infrequently. The information contained in this article could save you money, protect you from illness; or even save your life.
High Cholesterol: An Invented Disease
Medical science is expanding our knowledge of the human body at an exponential rate. Once of these advances has been the discovery of a compound in our body called Cholesterol. We discovered that this compound is found in foods that we eat and that it is naturally produced by our body. Cholesterol has a variety of functions. It is the backbone of our bodies hormones, it is a major component in our nervous system (40% of the brain is pure cholesterol), and it is present in every cell in our body. But the most notorious function of cholesterol is as a way to transport fat in our blood stream.
Everyone knows that water and oil don’t mix. Fat is essentially an oil-like compound that our body uses for energy. But it won’t dissolve in our blood on its own. Cholesterol binds to fat and carries it through our blood stream so that we can use it for energy. Once we discovered that cholesterol circulates in our blood stream we started to measure its concentration and explore whether cholesterol concentrations affected our health.
Of course once we could test for cholesterol, everyone wanted to know what was a normal level to have. In the 1980′s cholesterol levels of >200 were considered normal but research was showing that the plaque associated with heart attacks was mostly made of cholesterol. So somewhere along the way a doctor or scientist recommended that in order to prevent heart attacks and heart disease we needed to lower our cholesterol. Suddenly we had a new disease, Hypercholesterolemia - or high cholesterol.
Statin Medications: A Manufactured Cure
Now that cholesterol was considered a disease, the pharmaceutical companies set about finding a cure to help lower your cholesterol through a medication. They invested millions of dollars into research and development that led to the statin medications. And with the ability to patent this medicine, they can now sell it to people ‘diseased’ with high cholesterol.
Statin drugs go by the trade names Lipitor®, Crestor®, and Zocor® to name but a few. Together these drugs block the natural production and absorption of cholesterol by the body. It has been assumed that since these drugs lower cholesterol, that they are the answer to prevent heart disease. And they were marketed aggressively and effectively to our family physicians as the cure for heart disease. They are advertised in every media outlet in this entire country; and as of 2010 over 25 million people are taking these medicines to lower cholesterol in hopes of preventing death from heart attack or stroke.
Statin medications are prescribed to lower cholesterol and prevent heart disease. The general population views this information to mean “Take this medicine, and you won’t die of a heart attack.”
The Pharmaceutical Companies Want You To Be Sick
Since their inception, statin medications have become a $100 Billion industry. They are amongst the most readily prescribed, and the most profitable medications the world has ever seen. They are easily the most profitable drugs ever created. But the drug companies aren’t satisfied with a measly $ 100 Billion. And so we have been driven into a frenzied state of paranoia that is the result of a systematic manipulation of what is considered healthy, and what is considered diseased.
Once upon a time, cholesterol above 300 was considered hypercholesterolemia. Every few years, a panel of medical experts is assembled to re-evaluate these recommendations. And every time a panel is convened the recommendations on normal cholesterol get lower and lower. Currently a ‘healthy’ cholesterol level is less than 200 total cholesterol (optimal 160-180), with LDL cholesterol of less than 130 (optimal is below 100 for persons at risk for heart attack or stroke). What is more infuriating is that these healthy levels have no basis in scientific data or observation. They are in fact an arbitrary number determined by these so-called experts.
This means that currently over 200 Million people in the world are candidates for statin drug therapy. As a result; men, women, children, and diabetics are all being recommended these harmful drugs to prevent heart disease. Statin drugs have even been suggested to be of benefit in preventing Parkinson’s disease and Alzheimer’s disease.
The pharmaceutical companies have purposefully manipulated the definition of what constitutes disease so that even healthy individuals are being diagnosed with high cholesterol. More diagnoses means more prescriptions. And more prescriptions means more profits. In fact, in their latest move, the pharmaceutical companies have been promoting the use of statin medications as a preventative measure in person with normal cholesterol; and they continue to push to have statins approved for over-the-counter use without a doctor’s prescription or supervision. Unbelievable!
Part II: The Truth We Haven’t Been Told
The truth is that this group of drugs has never scientifically shown that taking them will decrease your risk of having a heart attack/stroke; or your risk of dying from a heart disease related event. However, they have been shown to have significant adverse side-effects. So much so that some studies have observed a 30% drop-out rate of their participants due solely to the nature of their adverse reactions to the statin medicines.
The pharmaceutical companies have continued to cleverly market these drugs based on a very select, but poorly designed, scientific studies. They choose to ignore the scientific consensus that Statin medications have NO EFFECT on reducing your risk for a coronary heart disease and that the adverse side effects make the drugs highly controversial.
What are the adverse side-effects of someone taking statin medications? The list is almost too numerous to have here in full detail. But I have taken the most common ones and explained how statin medications are contributing to a decline in health status despite a lowered cholesterol level.
Cancer
In every study done to date using rats, statin drugs have caused cancer. EVERY SINGLE STUDY! This is insane. Unfortunately, cancer takes much longer to appear in humans than it does in rats so the incidence of cancer has been less apparent in human trials. Still, the CARE (2002) study showed an increased incidence of breast cancer with a 1500% increased appearance versus the placebo group.
Manufacturers of statin drugs have acknowledged the fact that statin drugs depress the immune system, which can lead to cancer and infectious disease. Yet they choose to see only more potential patients and recommend statin use for inflammatory arthritis and as an immune suppressor for transplant patients. Talk about spinning a negative finding.
Muscle Pain and Weakness
Muscle pain and weakness is the most common side-effect of using statin medications, most likely due to its tendency to deplete CoQ10 within the body. In fact anyone on statin medications should be supplementing with CoQ10 as a general rule.
For most patients, muscle pain shows up briefly after starting statin therapy. These are usually corrected once the medication is terminated. However, in some cases it can take long-term use to appear and discontinuing the medication does not always correct the symptoms for several months. Active people are much less likely to develop these side-effect than sedentary people which makes them particularly dangerous for the senior citizen population.
In general, anyone suffering from muscle problems, fibromyalgia, coordination problems and fatigue needs to look at low cholesterol plus Co-Q10 deficiency as a possible cause.
Neuropathy
Neuropathy is characterized as tingling, weakness, or pain in the hands or feet and can be associated with difficulty walking, loss of grip strength, or generalized clumsiness. Studies have shown that taking statin for as little as 1 year can increase your risk for developing neurological problems by as much as 15%. This trend continues to increase as the time on the medication increases.
The most unfortunate problem is that patient’s that have these complications the damage that is done is often irreversible even after the drug is discontinued.
Heart Failure
Deaths attributed to heart failure have more than doubled from 1989-1997. This not surprisingly closely correlates with the introduction and FDA approval of Statin drugs in 1987. Again, CoQ10 depletion/deficiency is the likely culprit as CoQ10 is the direct energy source for heart muscle. CoQ10 depletion also increases as the dosage of statin medication is increased in an attempt to drive patients to ultra-low levels of blood cholesterol. Of nine studies currently available on CoQ10 depletion as the result of Statin drug use, 8 showed significant depletion of CoQ10 and associated heart muscle dysfunction.
A recent study in Britain actually showed that patients with heart failure benefited from having elevated cholesterol further indicating that use of statin medications is inappropriate in persons with a history of heart disease/failure.
Dizziness
Dizziness is usually associated with the potential for statin medications to cause blood pressure lowering. However, it could also be caused by neurological damage to the 8th cranial nerve which is directly responsible for our sense of balance.
Cognitive Impairment
Do you recall that 40% of the brain (by weight) is composed of cholesterol? It makes sense then that by limiting cholesterol that we would have an impact on the brain itself. Use of statin medication can cause progressive cognitive decline in some patients – changes that are irreversible. Memory, problem solving, and motor skills can all be negatively affected by use of statin medications. This is especially apparent in the elderly who seem to suffer from this side-effect more often – yet a reason for this has not bee proposed.
Depression
Our body’s hormones are built on a backbone of cholesterol. Without cholesterol, hormonal concentrations and balance is disrupted in the body. Not surprisingly yet another complication of statin therapy is depression which is directly associated with a change in brain chemistry and particularly in the role of serotonin, norepinephrine, testosterone, estrogen and the list goes on. Thus, other complaints such as irregular menstruation, early menopause, lack of sex drive, and even loss of bone density all could be attributed to statin drugs as the result of hormonal disruption.
Pancreatitis
Acute pancreatitis as the result of statin drug use has been reported in the literature and appears usually within the first two weeks of initiating the medication but can occur after several months to years of use as well. If left untreated (or undiagnosed) it can develop into necrotizing pancreatitis which will, most likely, result in death.
The symptoms of acute pancreatitis are moderate to severe abdominal pain. If you are on statin medication and develop this symptom consult your doctor immediately!
Think that this is just an over-exaggeration of the risks? Here are just some of the more recent controlled studies that have been performed and a brief summary of each.
Heart Protection Study (2002)
this Oxford University study found that persons taking Zocor® (simvastatin) had a lower mortality/death rate than those not taking the medication. However: This finding was determined to be independent of blood cholesterol concentration. Therefore, since statins lower cholesterol the finding of decreased mortality are likely not related to the fact that the participants were taking statin medication.
Honolulu Heart Program (2001)
Found that elderly individuals with artificially lowered serum/blood cholesterol had a greater risk of death than those with normal or slightly elevated blood cholesterol.
MIRACL (2001)
Found that use of Lipitor® did not decrease the risk of having a heart attack or stroke.
ALLHAT (2002)
Statin medications were used on 10,000 people over 4 year period. When compared to people who took normal preventative measures (healthy body weight maintained, no smoking, exercise) the cholesterol medication group showed no significant lowering in risk of heart attack, heart disease, or death.
PROSPER (2002)
This study showed no overall increase in life expectancy associated with use of statin medications. It showed no decrease in first-event heart attack or stroke versus a placebo. It did show a significant decrease in second-event heart attack versus placebo, but no difference in mortality from this event. A statistically significant increased cancer rate was found in the group taking statin medications.
J-LIT (2002)
A Japanese study with almost 50,000 patients followed over a 6 year period on Zocor® (simvastatin). This study followed the patients and categorized them by how much their blood cholesterol was lowered. What they found was that a lowered cholesterol level had absolutely no effect on mortality. Patients with cholesterol >200 lived as long as those that had cholesterol <80.
Meta-Analysis (2003)
This looked at 44 different trials using various statin medications. They found that:
- There was no difference in death rate/mortality between stain and placebo groups.
- Approximately 45% of enrolled patients reported a significant side-effect to the statin medications.
- Almost 4% of patients withdrew from the studies due to a significant side-effect.
Statins and Plaque (2003)
This study measured the progression of arterial plaque (arteriosclerosis) of two groups: i) high dose statin intervention ii) low-dose statin intervention. They found that statin use had no effect in slowing or stopping the progression of arterial plaque build up. Additionally they found that both groups had an average increase in arterial plaque build-up of 9.2% despite use of stain medications.
Statins and Women (2003)
This study concluded that the use of statins by females offers no benefit for the protection or prevention of heart disease.
ASCOT-LLA (2003)
This was a 5-year study investigating the use of Lipitor® in decreasing heart attack rates. The study was stopped after 3 years and did show a decreased rate of heart attacks in the treatment group but no change in death rates were present. You therefore had fewer heart attacks, but were just as likely to die from that heart attack as someone not taking the medication.
Cholesterol Levels in Dialysis Patients (2004)
This investigation did not use statin medications as an intervention. Instead, they looked at cholesterol levels in people receiving dialysis. They found that patients with higher cholesterol had a lower mortality rate than those with lower cholesterol rates. Once again the thought that lower cholesterol levels are beneficial to our health was unproven.
PROVE-IT (2004)
This study conducted at Harvard Medical was funded by Bristol-Myers-Squibb, a major pharmaceutical company and makers of Pravachol® . It received a great deal of media attention when it came out because the scientists found a 16% decrease in the relative risk for mortality of any cause for patients taking either Pravachol® or Lipitor® . However, when the data is examined closely, only a 1% actual decrease in mortality was present versus placebo. This study has become a poster-child for how a misinterpretation of scientific data and bias can result in studies that are funded by the company’s whose products are being ‘studied’.
Additionally of note: over 30% of the study’s participants withdrew due to significant adverse side-effects to taking either Pravachol® or Lipitor® .
REVERSAL (2004)
Conducted at the Cleveland Clinic, this study reported a 0.4% decrease in coronary plaque aggregation in patients whom used Lipitor® or Pravachol® over an 18 month period. The results led the researcher to comment that these results indicate that the use of statin medications should be widely expanded and that an estimated 200 million people could benefit from use of these drugs. This commentary shows not only tremendous scientific bias, but also calls into question the investigators ethics. To make such a bold statement on such a minuscule result leads one to believe the investigators set out with the intention of proving a point rather than scientifically exploring a hypothesis.
Critics of this study have countered that the measurements used to determine plaque accumulation were performed incorrectly and thus any data obtained is inherently invalid.
Why then, why?
With all this evidence is there really even any benefit to taking these medications? Most doctors are convinced that the benefits of statin drugs far outweigh the side effects. Contrary to this convention, Dr. Ravnskov has pointed out in his book The Cholesterol Myths, the results of the major studies up to the year 2000–the 4S, WOSCOPS, CARE, AFCAPS and LIPID studies–generally showed only small differences and these differences were often statistically insignificant and independent of the amount of cholesterol lowering achieved. In two studies, EXCEL and FACAPT/TexCAPS, more deaths occurred in the treatment group compared to controls. Dr. Ravnskov’s 1992 meta-analysis of 26 controlled cholesterol-lowering trials found an equal number of cardiovascular deaths in the treatment and control groups and a greater number of total deaths in the treatment groups.
An analysis of all the larger (and therefore more scientifically valid) controlled trials reported before 2000 found that long-term use of statins for the primary prevention of heart disease produced a 1 percent greater risk of death over 10 years compared to a placebo.
Something to think about isn’t it???
REFERENCES
- Hoffman G. N Engl J Med 1986;314:1610-24.
- Cranton, E M, MD, and J P Frackelton, MD, Journal of Holistic Medicine, Spring/Summer 1984, 6-37.
- Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003.
- Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003.
- Beatrice A. Golomb, MD, PhD on Statin Drugs, March 7, 2002. www.coloradohealthsite.org/topics/interviews/golomb.html
- Melissa Siig. Life After Lipitor: Is Pfizer product a quick fix or dangerous drug? Residents experience adverse reactions. Tahoe World, January 29, 2004.
- Jamil S, Iqbal P. Heart 2004 Jan;90(1):e3.
- Personal communication, Laura Cooper, May 1, 2003.
- Sinzinger H, O’Grady J. Br J Clin Pharmacol. 2004 Apr;57(4):525-8.
- Smith DJ and Olive KE. Southern Medical Journal 96(12):1265-1267, December 2003.
- Gaist D and others. Neurology 2002 May 14;58(9):1321-2.
- Statins and the Risk of Polyneuropathy. http://coloradohealthsite.org/CHNReports/statins_polyneuropathy.html
- The Struggles of Older Drivers, letter by Elizabeth Scherdt. Washington Post, June 21, 2003.
- Langsjoen PH. The clinical use of HMG Co-A reductase inhibitors (statins) and the associated depletion of the essential co-factor coenzyme Q10: a review of pertinent human and animal data. http://www.fda.gov/ohrms/dockets/dailys/02/May02/052902/02p-0244-cp00001-02-Exhibit_A-vol1.pdf
- Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003.
- Langsjoen PH. The clinical use of HMG Co-A reductase inhibitors (statins) and the associated depletion of the essential co-factor coenzyme Q10: a review of pertinent human and animal data. http://www.fda.gov/ohrms/dockets/dailys/02/May02/052902/02p-0244-cp00001-02-Exhibit_A-vol1.pdf
- Clark AL and others. J Am Coll Cardiol 2003;42:1933-1943.
- Personal communication, Jason DuPont, MD, July 7, 2003
- Sandra G Boodman. Statins’ Nerve Problems. Washington Post, September 3, 2002.
- Eleanor Laise. The Lipitor Dilemma, Smart Money: The Wall Street Journal Magazine of Personal Business, November 2003,
- King, DS. Pharmacotherapy 25(12):1663-7, Dec, 2003.
- Muldoon MF and others. Am J Med 2000 May;108(7):538-46.
- Email communication, Beatrice Golomb, July 10, 2003.
- Duane Graveline, MD. Lipitor: Thief of Memory, 2004, www.buybooksontheweb.com.
- Colomb, B. Geriatric Times, May/June 2004, Vol V, Issue 3
- Newman TB, Hulley SB. JAMA 1996;27:55-60
- Sacks FM and others. N Eng J Med 1996;385;1001-1009.
- Heart Protection Study Collaborative Group. Lancet 2002;360:7-22.
- Leung BP and others. J Immunol. Feb 2003 170(3);1524-30; Palinski W. Nature Medicine Dec 2000 6;1311-1312.
- J Pharm Technol 2003;19:283-286. Singh S and Loke YK, Drug Safety, Vol 29, o 12, 2006, 1123-1132 (10).
- Partonen T and others. British Journal of Psychiatry. 1999 Sep;175:259-62.
- Low Cholesterol Linked to Depression. BBC Online Network, May 25,1999.
- Uffe Ravnskov, MD, PhD. The Cholesterol Myths. NewTrends Publishing, 2000.
- Ravnskov U. BMJ. 1992;305:15-19.
- Jackson PR. Br J Clin Pharmacol 2001;52:439-46.
- Schatz IJ and others. Lancet 2001 Aug 4;358:351-355.
- Schwartz GG and others. J Am Med Assoc. 2001;285:1711-8.
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. JAMA 2002;288:2998-3007.
- Heart Protection Study Collaborative Group. Lancet 2002;360:7-22.
- Medical Research Council/British Heart Foundation Heart Protection Study.Press release. Life-saver: World’s largest cholesterol-lowering trial reveals massive benefits for high-risk patients. Available at www.ctsu.ox.ac.uk/~hps/pr.shtml.
- Kmietowicz A. BMJ 2001;323:1145
- Ravnskov U. BMJ 2002;324:789
- Email communication, Eddie Vos, February 13, 2004 and posted at www.health-heart.org/comments.htm#PetoCollins.
- Shepherd J and others. Lancet 2002;360:1623-1630.
- Matsuzaki M and others. Circ J. 2002 Dec;66(12):1087-95.
- Hecht HS, Harmon SM. Am J Cardiol 2003; 92:670-676
- Hecht HS and others. Am J Cardiol 2003;92:334-336
- Jenkins AJ. BMJ 2003 Oct 18;327(7420):933.
- Circulation, 2004 Feb 17;109(6):714-21.
- Sever PS and others. Lancet 2003;361:1149-1158.
- Liu Y and others. JAMA 2004;291:451-459.
- Cannon CP and others. N Engl J Med 2004 Apr 8;350(15):1495-504. Epub 2004 Mar 08.
- Gina Kolata. Study of Two Cholesterol Drugs Finds One Halts Heart Disease. The New York Times, November 13, 2003.
- Extra-Low Cholesterol, The New York Times, March 10, 2003
- Rob Stein. Striking Benefits Found in Ultra-Low Cholesterol, The Washington Post, March 9, 2004
- Dr. Malcolm Kendrick. PROVE IT- PROVE WHAT? http://www.redflagsweekly.com/applications/ui/login.php?Next=/kendrick/2004_mar10.php&e=4
- Health Sciences Institute e-alert, www.hsibaltimore.com, March 11, 2004
- Email communication, Joel Kauffman, April 15, 2004.
- Nissen SE and others. JAMA 2004 Mar 3;291(9):1071-80.
- Dr. Malcolm Kendrick. PROVE IT- PROVE WHAT? http://www.redflagsweekly.com/applications/ui/login.php?Next=/kendrick/2004_mar10.php&e=4
- Scott Hensley. The Statin Dilemma: How Sluggish Sales Hurt Merck, Pfizer. The Wall Street Journal, July 25, 2003.
- Ravnskov, U. Unpublished letter. ravnskov (at) tele2.se.
- Cholesterol–And Beyond: Statin Drugs Have Cut Heart Disease. Now They Show Promise Against Alzheimer’s, Multiple Sclerosis & Osteoporosis. Newsweek, July 14. 2003.
- John O’Neil. Treatments: Statins and Diabetes: New Advice. New York Times, April 20, 2004.
- Peter Jaret. Statins’ Burst of Benefits. Los Angeles Times, July 2. 2003.
- Behind the ‘Boomer Coalition,’ A Heart Message from Pfizer, Wall Street Journal, March 10, 2004
- Paul J. Fallon, personal communication, March, 2004.
- Uffe Ravnskov, MD, PhD. The Cholesterol Myths. NewTrends Publishing, 2000, pp 208-210.
Much of the information contained in this article has come from:
Dangers of Statin Drugs: What You Haven’t Been Told About Popular Cholesterol Lowering Medicines
written by Sally Fallon and Mary G. Enig, PhD
Part III: Lowering Cholesterol Naturally
A summary of suggestions:
- Choose lower fat dairy products: Skim or 1% Milk, non-fat yogurt.
- Avoid vegetable oil and hydrogenated soy bean oil.
- Choose olive oil or peanut oil.
- Eat high fiber foods (broccoli, whole wheat, bran, and brown rice).
- Enjoy fish and seafood at least once a week.
- “Cholesterol free” doesn’t necessarily mean fat free. Usually these products are high in saturated fats!
- Supplement with a high-quality multivitamin and a cholesterol complex containing Policosanol AND Gum Guggal.
Heart disease is the number one killer in North America. While heart attacks occur suddenly, they are predictable and preventable. Modern medicine has pinpointed the risk factors associated with heart disease and as many of us know, the single biggest factor is our cholesterol.
Cholesterol is a compound that occurs naturally in our bodies. It helps package and transport fats to our body’s cells where they can be used for energy and cell replication. It’s important to realize that cholesterol and fats are not the enemy. Too much of the wrong kind of cholesterol is the problem.
Step 1 – Out with the bad.
The first and foremost cause of heart disease is dietary. It’s all about the fat! Modern dietary suggestions recommend that our total fat intake not exceed 30% of our total dietary intake and saturated fats should be <10% of this amount. Saturated fat can be found in dairy products (particularly cheese, whole milk, and butter); red meats and processed meats (salami, bacon, bologna) and egg yolks. These foods are also high in cholesterol (discussed later). Limiting our fat consumption, particularly saturated fats and cholesterol, is the first step to being heart healthy.
Bad cholesterol (or LDL) sticks to the lining of your arteries and causes a build up of fat on the walls. Overtime, this builds similar to sludge in a pipe. Eventually it will begin to narrow the artery which causes a restriction of the blood flow. Heart attacks occur due to restricted blood flow to the arteries of the heart.
Current cholesterol medications (like Lipitor, Crestor or Plavix) aim at eliminating cholesterol at its source – the liver. Others prevent the absorption of cholesterol in the intestines. Both types have serious side effects including permanent liver damage. Unfortunately, with heart disease such a prominent killer in our society, the medical community seems to accept the “side-effects” of these medications as a necessary evil. Yet natural remedies exist that are as good, or better, than our current medications. You won’t find them advertised on television, but they are proven to work without any side-effects.
Step 2 – Choose the right fats and leaner meats
Remember our bodies still need fat to function. Choosing the right types of fat is the first step to reducing your cholesterol naturally. Monounsaturated fats are a great substitute for the more harmful types. These are found in olive oil (extra virgin of course), canola oil, and peanut oil. Try substituting your vegetable oil (bad fat) for canola – and use olive oil whenever you can! Second, the best oil we can consume is Omega-3 oils found in fish and seafood. Fish in particular is a great source of Omega-3 fats and you should try to have fish 1-3 meals each week. Fish is also a lean meat and contains very little bad fats. Chicken and turkey are also very lean and can be eaten without worry and are high quality sources of protein.
Choosing good fats will increase your good cholesterol (or HDL). HDL is like a vacuum cleaner for bad fats. It travels through your blood stream sucking up the bad fat and cholesterol. As a result HDL helps prevent fat from depositing on your artery walls. High levels of HDL are a good thing.
Step 3 – Eat more fiber.
The second step in lowering your cholesterol naturally is to eat a diet high in fiber. Fiber is a cholesterol cruncher. It binds to cholesterol naturally and prevents its digestion. For vegetables, the greener it is the more fiber it contains. Whole wheat, bran, and soluable fiber (Metamucil or Benefiber) are also great ways to add fiber to the diet.
Step 4 – Exercise.
Of course it’s been drilled into our heads that we need to exercise. But you don’t have to run marathons to be heart healthy. Experts insist that 20-30 minutes of moderate intensity exercise (walking, jogging, cycling) done a mere 3 times a week will drastically reduce your risk for heart disease. New studies even show that 20 minutes of brisk exercise after a high-fat meal may reduce the amount of bad cholesterol absorbed into our bodies.
Step 5 – Add Supplements and Vitamins.
The first line of defense is always a good multivitamin. It gives us everything that we may not be getting from our diet. But two specific natural compounds have been tested against the cholesterol-lowering drugs with surprising results.
Policosanol is a natural compound found in sugar cane and beeswax. When tested against the cholesterol drugs, it outperformed them both in lowering LDL (an amazing 24%) and raising HDL. And it did it without major side-effects. Dosages should be between 1.0-2.0 mg per tablet.
Gum guggal is derived from the Mukul Myrrh tree and has been shown to lower cholesterol 14-27% and reduce blood fats 22-33%! The recommended dosage is 500mg standardized to 2.5% guggulsterone content (very important). It has a proven safety record, no toxicity, and is frequent prescribed in India for high cholesterol before pharmacological intervention.
Now that you know what medical doctors don’t, you can take action immediately. Although these interventions do not require supervision, I would recommend discussing them with your family doctor. And never discontinue any prescribed medication without properly discussing it with your physician.
Written by:
- Dr. Shane R. Conrad D.C.